论文部分内容阅读
目的:评价目前市面上4个厂家5批次人参多糖注射液的质量。方法:从药物分析的角度,对人参多糖注射液进行常规检查,并测定其相对分子质量和单糖组成。结果:4个厂家的产品均符合相关质量标准和2010年版《中国药典》中的相关规定,但是相对分子质量分布和单糖组成差异很大。结论:建议提高人参多糖注射液的质量标准,保障安全用药。
Objective: To evaluate the quality of 5 batches of ginseng polysaccharide injection of 4 plants currently on the market. Methods: From the perspective of drug analysis, ginseng polysaccharide injection was routinely examined and its relative molecular mass and monosaccharide composition were determined. Results: The products of the four manufacturers all met the relevant quality standards and the relevant provisions in the 2010 edition of “Chinese Pharmacopoeia”, but the relative molecular mass distribution and monosaccharide composition vary greatly. Conclusion: It is suggested to improve the quality standards of ginseng polysaccharide injection to ensure safe medication.